コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 wnregulation of the T-cell effector cytokine interleukin 21.
2 T follicular helper cells (cTfh) expressing interleukin 21.
3 ecules interferon-gamma, interleukin-17, and interleukin-21.
4 expression is regulated by interleukin-6 and interleukin-21.
5 tched to IgG1 and IgG2b when stimulated with interleukin-21.
7 de-pulsed dendritic cells in the presence of interleukin-21 and enriched by peptide-major histocompat
8 SIV-infected rhesus macaques that sequential interleukin-21 and interferon alpha therapy generate ter
10 specialization of CD4(+) T cells to produce interleukin-21 and promote antibody-mediated immunity an
11 pression was associated with interleukin 27, interleukin 21, and interferon gamma expression, rather
12 scriptional regulator Bcl6, the receptor for interleukin-21, and the ancestral polarity protein atypi
13 pecific CXCR5(+) CD4(+) T cells that secrete interleukin-21 are strongly associated with B cell memor
14 mediated by the cytokines interleukin-6 and interleukin-21 but is independent of TH1, TH2, and TH17
15 ning of calcium signaling, or treatment with interleukin-21 can correct mitochondrial defects and res
16 ls, IgM+CD21-/low-memory B cells, CD4+CXCR5+ interleukin 21+ cells, and T-helper 17 cells, compared w
18 ), CD4+IL17A+ cells (P < .01), and CD4+CXCR5+interleukin 21+ follicular T-helper (Tfh) cells (P < .01
19 69+ Ag.pTfh, with induction of intracellular interleukin 21 (IL-21) and inducible costimulator (ICOS)
20 ophages were also analyzed for expression of interleukin 21 (IL-21) and negative regulators of immune
23 antigen-primed plasma cells failed to induce interleukin 21 (IL-21) or the transcriptional repressor
25 uantification of human and cynomolgus monkey interleukin 21 (IL-21) was developed, qualified, and imp
26 zed proximally to mutating B cells, secreted interleukin 21 (IL-21), induced expression of the transc
27 nsforming growth factor beta1 (TGFbeta1) and interleukin 21 (IL-21), produced by follicular helper T
29 efficacy of CD20-targeted therapy, we fused interleukin 21 (IL-21), which induces direct lymphoma cy
31 lly, Foxp1 directly and negatively regulated interleukin 21 (IL-21); Foxp1 also dampened expression o
32 was shown to be implicated in regulation of interleukin-21 (IL-21) and IL-17 secretion in mice and h
33 t specialized in helping B lymphocytes, with interleukin-21 (IL-21) and inducible costimulatory molec
34 ighlights the recent identification of human interleukin-21 (IL-21) and interleukin-21 receptor (IL-2
35 itically dependent on CD4(+) T cell help via interleukin-21 (IL-21) and that exploitation of this dev
36 mmac-dependent cytokine expression indicated interleukin-21 (IL-21) as a primary candidate optimizing
37 ould be treated by eliminating production of interleukin-21 (IL-21) by donor T cells or IL-21 recepto
39 ronic HIV-1 control, it is not known whether interleukin-21 (IL-21) contributes to early HIV-1 immuni
45 and indirect immune cell-mediated effects of interleukin-21 (IL-21) in mantle cell lymphoma (MCL), pr
46 y, we have examined the role of the cytokine interleukin-21 (IL-21) in regulating humoral immunity du
54 hronic viral infection, we demonstrated that interleukin-21 (IL-21) is an essential component of CD4+
57 phocytic leukemia (B-CLL) cells treated with interleukin-21 (IL-21) produce low levels of granzyme B.
59 -cell activation, as well as the addition of interleukin-21 (IL-21) to IL-7 and IL-15 to promote stem
61 urthermore, we identified a crucial role for interleukin-21 (IL-21), a cytokine secreted by intrathyr
64 teractions, was maintained by T-cell-derived interleukin-21 (IL-21), and promoted repeated rounds of
65 L) expressed on B cells and was dependent on interleukin-21 (IL-21), IL-6, and signal transducer and
67 of chronic viral infection demonstrate that interleukin-21 (IL-21), produced primarily by CD4 T cell
68 found to increase SOX11 expression, whereas interleukin-21 (IL-21)-induced STAT3 activation or overe
69 found that a small subset of gp120-specific interleukin-21 (IL-21)-secreting CXCR5(+) CD4(+) T cells
78 issue of Immunity have identified a role for interleukin-21 in the development of these specialized c
79 se 1 dose-escalation study of membrane-bound interleukin 21 (mbIL21) expanded donor NK cells infused
80 with enhanced levels of SARS-CoV-2-specific interleukin-21 memory T cells (odd ratio, 3.84 [1.89-7.7
81 sed vaccine, we compared SARS-CoV-2-specific interleukin-21 memory T-cell and B-cell responses by enz
82 reviously unidentified mechanism mediated by interleukin-21/p38 mitogen-activated protein kinase/a di
83 notype (CD4(+) PD1(hi) CXCR5(hi)), function (interleukin 21 positive [IL-21(+)]), and gene expression
85 fication of human interleukin-21 (IL-21) and interleukin-21 receptor (IL-21R) deficiencies as novel e
86 This cluster co-expressed high levels of the interleukin-21 Receptor (IL-21R); Type-1 transcription f
88 homozygous loss-of-function mutations in the interleukin-21 receptor gene (IL21R; c.G602T, p.Arg201Le
91 ated Th1 follicular helper cells, and plasma interleukin-21, suggesting an alternative inflammatory m
92 unction, which was not enhanced by exogenous interleukin 21 supplementation in HIV-infected, older va
93 ly competent "Tfh-like" cells that expressed interleukin-21, Tfh cell markers, and Bcl6 and rescued G
94 Active production of both interleukin 27 and interleukin 21, together with production of interferon g